Futura Medical PLC (LSE:FUM) - Overview

Stock Report

Futura Medical PLC FUM

Last Price
GBX55.95

Day Change
0.20|0.36%

As of 09/12/2016
09:24:38 GMT | GBX
Minimum 15 Minutes Delay.

Last Close55.75p
Day Range55.95 - 55.95
Mkt Cap66.98Mil
52-Wk Range14.31 - 95.60
Yield %0.00
ISINGB0033278473
Volume4,883
P/E-10.91
P/S1,929.31
P/CF-10.43

Share Price

Total Returns 08/12/2016

 Chg (%)  
More ...
Futura Medical PLC0.45 
FTSE 100 TR GBP1.73
 
Financials
201320142015
More ...
Income Statement
Turnover0.370.040.03
Operating Profit-2.53-3.53-6.12
Net Profit-2.21-3.00-5.08
Reported EPS-2.85-3.35-5.13
Balance Sheet
Current Assets1.4610.325.50
Non Current Assets0.010.010.02
Total Assets1.4710.335.52
Current Liabilities0.480.610.73
Total Liabilities0.480.610.73
Total Equity0.999.724.79
Cash Flow
Operating Cash Flow-2.28-3.38-5.84
Net Change in Cash-1.838.50-5.30
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-3.94-3.32--16.80---
2017-6.61-3.12--17.87---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
08/01/2016PurchaseMr. Jonathan Freeman35.5013,4214,764.00
08/01/2016PurchaseLisa Arnold35.5013,7144,868.00
08/01/2016PurchaseMr. John Clarke35.5042,58315,117.00

Company Profile

Futura Medical PLC is engaged in the research & development of medical devices & pharmaceutical drugs and their commercial exploitation with the focus being on OTC products for sexual healthcare & pain relief management.
 

Sector

Drug Manufacturers - Major

Market Position

994 of 1863 Companies

Index

FTSE AIM All Share

Outlook

(13/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-17.8013.3915.97
Div Yld (E)0.004.244.18
PEG (E)0.000.220.27
ROCE-127.00204.18-30.67
Op Mrgn-21,089.66-17.37-33.06
EPS Grwth0.009.7722.66
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. John Clarke
Chief ExecutiveJames Barder
Finance Director & Company SecretaryDerek Martin
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.